Study of Tiotropium Hydrofluoralkane in Patients With Chronic Obstructive Pulmonary Disease

Study Title
A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease
Teva Identifier
TBB-COPD-20009
ClinicalTrials.gov Identifier
NCT02203474
Study Status
Withdrawn
Trial Condition(s)
Chronic Obstructive Pulmonary Disease | COPD
Interventions
Drug: Tiotropium HFA BAI 5 mcg | Drug: Tiotropium 18 mcg Capsule | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
40 Years to 80 Years
Trial Duration
08/01/2014 - 08/01/2014
Phase
Phase 2

Study Type

Interventional